West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
314.50
-2.82 (-0.89%)
Jun 5, 2026, 4:00 PM EDT - Market closed

WST Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $352.36. The average 1-year stock price forecast is 12.04% higher than the current stock price, while the lowest is $310 (-1.43%) and the highest is $400 (+27.19%).

Price Target: $352.36 (+12.04%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$310$352.36$351.5$400
Change-1.43%+12.04%+11.76%+27.19%

Analyst Ratings

The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy111110101011
Buy222222
Hold333332
Sell000000
Strong Sell000000
Total161615151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 2, 2026
Wolfe Research
Wolfe Research
Buy
Reiterates
$375
BuyReiterates$375+19.24%Jun 1, 2026
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$315$325
HoldReiterates$315$325+3.34%May 29, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 21, 2026
Barclays
Barclays
Hold
Reiterates
$275$310
HoldReiterates$275$310-1.43%Apr 27, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.33B
from 3.07B
Increased by 8.36%
Revenue Next Year
3.54B
from 3.33B
Increased by 6.20%
EPS This Year
8.61
from 7.29
Increased by 18.10%
EPS Next Year
9.54
from 8.61
Increased by 10.78%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.83B2.89B2.95B2.89B3.07B3.33B
Revenue Growth
31.89%1.95%2.18%-1.92%6.25%8.36%
Gross Profit
1.18B1.14B1.13B998.50M1.10B1.24B
Gross Margin
41.59%39.36%38.31%34.51%35.91%37.14%
Operating Income
768.60M763.80M706.20M593.60M638.70M741.31M
Net Income
661.80M585.90M593.40M492.70M493.70M604.69M
EPS
----7.298.61
EPS Growth
----8.00%18.10%
Forward PE
53.5534.8442.2345.9036.6936.53
Dividend / Share
0.690.730.770.810.850.90
Dividend Growth
-5.80%5.48%5.19%4.94%5.41%
Free Cash Flow
210.05M246.54M196.35M206.73M273.88M445.67M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.4B
Avg3.3B
Low3.3B

Revenue Growth

Revenue Growth202620272028
High
10.8%
Avg
8.4%
Low
7.4%

EPS Forecast

EPS202620272028
High-
Avg8.61
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
18.1%
Low-